Replies to post #197638 on Avid Bioservices Inc (CDMO)

[biopharm]

ESMO: Immunotherapy set to revolutionise cancer treatment

Sulaco... great post! We're in much bigger times from years past and as much as I have no idea why some try to paint a negative picture re: Peregrine

Your post clearly shows how important these most recent times are... and how the past has no relevance, because Immunotherapy may have been on the radar, but not ready to create a paradigm shift in the many treatments of cancer.

------------ A couple other good points from your post below!

Was oncology on the cusp of a paradigm shift in any of the years (2007, 2009, 2010) you mentioned in your post? Were scientific articles trumpeting the coming shift in immuno-oncology at your time points?

Answer: NO. AND NO.

Does PPHM have THE unique upstream checkpoint inhibitor that crushes myeloid-derived suppressor cells (MDSCs) in the tumor micro-environment, as well as potentiating multiple downstream monoclonal antibodies from big-time BPs? Has PPHM worked out its understanding of Bavi's MOA just recently, (i.e. within the past 2 years)?

Answer: YES. AND YES.

[dia76ca]

Outstanding post Joe. Immunotherapy is indeed here to stay...and PS targeting has already proven to be both safe and effective.